The risk of major cardiac events was 50% higher in adult-onset type 1 diabetes than in population controls, and the risk of ...

Diabetes is a chronic, lifelong, and irreversible condition where the body is unable to control blood sugar levels. It occurs ...

Results showed that people diagnosed with diabetes as adults had a higher risk of heart disease, as well as premature death ...

Netherlands: A new study published in Diabetes, Obesity and Metabolism highlights the long-term benefits of intermittently ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the ...

In 2024, 4% of U.S. adults were prescribed a GLP-1 therapy — a 363.7% increase from 0.9% in 2019, according to a Fair Health analysis of more than 51 billion commercial claim records.  Fair Health ...

Inhaled insulin was noninferior to usual care in glycemic control outcomes after 17 weeks among patients with type 1 diabetes.

The results were quite surprising. They found that people who took GLP-1 agonists had a 30% lower risk of developing dementia ...

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk of death from any cause compared to those who took the other type of ...

For the new study, researchers tracked nearly 10,200 Swedish adults diagnosed with type 1 diabetes between 2001 and 2020, comparing them to nearly 510,000 healthy people. Results showed that ...